{"entity":{"type":"insider","cik":"0001585001","url":"/insider/0001585001","json_url":"/insider/0001585001.json","name":"Yeshwant Krishna","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":24,"n_filings":9,"first":"2014-06-17","last":"2023-12-05","span_basis":"filed_date"},"name_variants":[{"name":"Yeshwant Krishna","source":"filing","n_filings":9,"first_seen":"2014-06-17","last_seen":"2023-12-05"}],"transactions":[{"id":8065277,"accession":"0000950170-23-068199","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-068199","line_url":"/filing/0000950170-23-068199#line-1","is_derivative":false,"issuer_cik":"0001585001","issuer_name":"Verve Therapeutics, Inc.","issuer_ticker":"VERV","issuer_name_source":null,"issuer_url":"/issuer/0001585001","owner_cik":"0001585001","owner_name":"Yeshwant Krishna","owner_display_name":"Yeshwant Krishna","owner_url":"/insider/0001585001","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1800000.0,"shares_display":"1,800,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":18000000.0,"total_display":"18,000,000.00","total_whole":"18,000,000","shares_owned_after":1800000.0,"shares_owned_after_display":"1,800,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-12-01","filed_date":"2023-12-05","scope":"insider"},{"id":6264467,"accession":"0000899243-22-035380","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-035380","line_url":"/filing/0000899243-22-035380","is_derivative":false,"issuer_cik":"0001585001","issuer_name":"Verve Therapeutics, Inc.","issuer_ticker":"VERV","issuer_name_source":null,"issuer_url":"/issuer/0001585001","owner_cik":"0001585001","owner_name":"Yeshwant Krishna","owner_display_name":"Yeshwant Krishna","owner_url":"/insider/0001585001","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":48583.0,"shares_display":"48,583","price_per_share":31.13858643970113,"price_display":"31.14","price_state":"stated","total_value":1512805.945,"total_display":"1,512,805.94","total_whole":"1,512,806","shares_owned_after":4260940.0,"shares_owned_after_display":"4,260,940","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-04","filed_date":"2022-11-08","scope":"insider","n_lines":3},{"id":6974774,"accession":"0000899243-22-035228","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000899243-22-035228","line_url":"/filing/0000899243-22-035228","is_derivative":false,"issuer_cik":"0001585001","issuer_name":"Verve Therapeutics, Inc.","issuer_ticker":"VERV","issuer_name_source":null,"issuer_url":"/issuer/0001585001","owner_cik":"0001585001","owner_name":"Yeshwant Krishna","owner_display_name":"Yeshwant Krishna","owner_url":"/insider/0001585001","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":49568.0,"shares_display":"49,568","price_per_share":32.79328178663654,"price_display":"32.79","price_state":"stated","total_value":1625497.3916,"total_display":"1,625,497.39","total_whole":"1,625,497","shares_owned_after":4310385.0,"shares_owned_after_display":"4,310,385","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-03","filed_date":"2022-11-04","scope":"insider","n_lines":3},{"id":6974765,"accession":"0000899243-22-035228","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-035228","line_url":"/filing/0000899243-22-035228","is_derivative":false,"issuer_cik":"0001585001","issuer_name":"Verve Therapeutics, Inc.","issuer_ticker":"VERV","issuer_name_source":null,"issuer_url":"/issuer/0001585001","owner_cik":"0001585001","owner_name":"Yeshwant Krishna","owner_display_name":"Yeshwant Krishna","owner_url":"/insider/0001585001","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28652.0,"shares_display":"28,652","price_per_share":35.94277464749407,"price_display":"35.94","price_state":"stated","total_value":1029832.3792,"total_display":"1,029,832.38","total_whole":"1,029,832","shares_owned_after":4367128.0,"shares_owned_after_display":"4,367,128","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-02","filed_date":"2022-11-04","scope":"insider","n_lines":3},{"id":6645753,"accession":"0000899243-22-034842","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000899243-22-034842","line_url":"/filing/0000899243-22-034842","is_derivative":false,"issuer_cik":"0001585001","issuer_name":"Verve Therapeutics, Inc.","issuer_ticker":"VERV","issuer_name_source":null,"issuer_url":"/issuer/0001585001","owner_cik":"0001585001","owner_name":"Yeshwant Krishna","owner_display_name":"Yeshwant Krishna","owner_url":"/insider/0001585001","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31963.0,"shares_display":"31,963","price_per_share":36.787940737728,"price_display":"36.79","price_state":"stated","total_value":1175852.9498,"total_display":"1,175,852.95","total_whole":"1,175,853","shares_owned_after":4389487.0,"shares_owned_after_display":"4,389,487","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-01","filed_date":"2022-11-02","scope":"insider","n_lines":3},{"id":6645744,"accession":"0000899243-22-034842","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-22-034842","line_url":"/filing/0000899243-22-034842","is_derivative":false,"issuer_cik":"0001585001","issuer_name":"Verve Therapeutics, Inc.","issuer_ticker":"VERV","issuer_name_source":null,"issuer_url":"/issuer/0001585001","owner_cik":"0001585001","owner_name":"Yeshwant Krishna","owner_display_name":"Yeshwant Krishna","owner_url":"/insider/0001585001","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":53696.0,"shares_display":"53,696","price_per_share":38.636825054007744,"price_display":"38.64","price_state":"stated","total_value":2074642.9581,"total_display":"2,074,642.96","total_whole":"2,074,643","shares_owned_after":4448777.0,"shares_owned_after_display":"4,448,777","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-31","filed_date":"2022-11-02","scope":"insider","n_lines":4},{"id":5320048,"accession":"0001209191-17-048412","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-048412","line_url":"/filing/0001209191-17-048412#line-1","is_derivative":false,"issuer_cik":"0001488613","issuer_name":"Foundation Medicine, Inc.","issuer_ticker":"FMI","issuer_name_source":null,"issuer_url":"/issuer/0001488613","owner_cik":"0001585001","owner_name":"Yeshwant Krishna","owner_display_name":"Yeshwant Krishna","owner_url":"/insider/0001585001","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4800.0,"shares_display":"4,800","price_per_share":40.01,"price_display":"40.01","price_state":"stated","total_value":192048.0,"total_display":"192,048.00","total_whole":"192,048","shares_owned_after":5786.0,"shares_owned_after_display":"5,786","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-08","filed_date":"2017-08-10","scope":"insider"},{"id":4084297,"accession":"0001209191-17-048081","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-17-048081","line_url":"/filing/0001209191-17-048081#line-3","is_derivative":false,"issuer_cik":"0001488613","issuer_name":"Foundation Medicine, Inc.","issuer_ticker":"FMI","issuer_name_source":null,"issuer_url":"/issuer/0001488613","owner_cik":"0001585001","owner_name":"Yeshwant Krishna","owner_display_name":"Yeshwant Krishna","owner_url":"/insider/0001585001","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18072.0,"shares_display":"18,072","price_per_share":36.85,"price_display":"36.85","price_state":"stated","total_value":665953.2,"total_display":"665,953.20","total_whole":"665,953","shares_owned_after":5786.0,"shares_owned_after_display":"5,786","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-04","filed_date":"2017-08-08","scope":"insider"},{"id":8196715,"accession":"0000903423-15-000387","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000903423-15-000387","line_url":"/filing/0000903423-15-000387#line-3","is_derivative":false,"issuer_cik":"0001488613","issuer_name":"Foundation Medicine, Inc.","issuer_ticker":"FMI","issuer_name_source":null,"issuer_url":"/issuer/0001488613","owner_cik":"0001585001","owner_name":"Yeshwant Krishna","owner_display_name":"Yeshwant Krishna","owner_url":"/insider/0001585001","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":114481.0,"shares_display":"114,481","price_per_share":32.33,"price_display":"32.33","price_state":"stated","total_value":3701170.73,"total_display":"3,701,170.73","total_whole":"3,701,171","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-06-15","filed_date":"2015-06-15","scope":"insider"},{"id":8196714,"accession":"0000903423-15-000387","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000903423-15-000387","line_url":"/filing/0000903423-15-000387#line-2","is_derivative":false,"issuer_cik":"0001488613","issuer_name":"Foundation Medicine, Inc.","issuer_ticker":"FMI","issuer_name_source":null,"issuer_url":"/issuer/0001488613","owner_cik":"0001585001","owner_name":"Yeshwant Krishna","owner_display_name":"Yeshwant Krishna","owner_url":"/insider/0001585001","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":53645.0,"shares_display":"53,645","price_per_share":33.72,"price_display":"33.72","price_state":"stated","total_value":1808909.4,"total_display":"1,808,909.40","total_whole":"1,808,909","shares_owned_after":114481.0,"shares_owned_after_display":"114,481","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-06-12","filed_date":"2015-06-15","scope":"insider"},{"id":8196713,"accession":"0000903423-15-000387","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000903423-15-000387","line_url":"/filing/0000903423-15-000387#line-1","is_derivative":false,"issuer_cik":"0001488613","issuer_name":"Foundation Medicine, Inc.","issuer_ticker":"FMI","issuer_name_source":null,"issuer_url":"/issuer/0001488613","owner_cik":"0001585001","owner_name":"Yeshwant Krishna","owner_display_name":"Yeshwant Krishna","owner_url":"/insider/0001585001","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15734.0,"shares_display":"15,734","price_per_share":35.14,"price_display":"35.14","price_state":"stated","total_value":552892.76,"total_display":"552,892.76","total_whole":"552,893","shares_owned_after":168126.0,"shares_owned_after_display":"168,126","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-06-11","filed_date":"2015-06-15","scope":"insider"},{"id":8196712,"accession":"0000903423-15-000337","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000903423-15-000337","line_url":"/filing/0000903423-15-000337#line-1","is_derivative":false,"issuer_cik":"0001488613","issuer_name":"Foundation Medicine, Inc.","issuer_ticker":"FMI","issuer_name_source":null,"issuer_url":"/issuer/0001488613","owner_cik":"0001585001","owner_name":"Yeshwant Krishna","owner_display_name":"Yeshwant Krishna","owner_url":"/insider/0001585001","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8600.0,"shares_display":"8,600","price_per_share":38.57,"price_display":"38.57","price_state":"stated","total_value":331702.0,"total_display":"331,702.00","total_whole":"331,702","shares_owned_after":183860.0,"shares_owned_after_display":"183,860","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-05-14","filed_date":"2015-05-18","scope":"insider"},{"id":6905989,"accession":"0001181431-14-024274","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-024274","line_url":"/filing/0001181431-14-024274#line-1","is_derivative":false,"issuer_cik":"0001488613","issuer_name":"Foundation Medicine, Inc.","issuer_ticker":"FMI","issuer_name_source":null,"issuer_url":"/issuer/0001488613","owner_cik":"0001585001","owner_name":"Yeshwant Krishna","owner_display_name":"Yeshwant Krishna","owner_url":"/insider/0001585001","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1300000.0,"shares_display":"1,300,000","price_per_share":22.4,"price_display":"22.40","price_state":"stated","total_value":29120000.0,"total_display":"29,120,000.00","total_whole":"29,120,000","shares_owned_after":1144653.0,"shares_owned_after_display":"1,144,653","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-06-13","filed_date":"2014-06-17","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":24,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":23,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":24},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001840574","name":"Verve Therapeutics, Inc.","url":"/issuer/0001840574","role":"Director, Ten percent owner","n_filings":4,"first_seen":"2022-11-02","last_seen":"2023-12-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001488613","name":"Foundation Medicine, Inc.","url":"/issuer/0001488613","role":"Director, Ten percent owner","n_filings":5,"first_seen":"2014-06-17","last_seen":"2017-08-10"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001585001","retrieved_at":"2026-08-27T23:31:40+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}